Drugs / Autologous, Unfractionated Bone Marrow Mononuclear Cells
last change Sep 2010 re-read 3 minutes ago

Autologous, Unfractionated Bone Marrow Mononuclear Cells

Developed for
acute myocardial infarction
Investigated by
Allina Health System · Minneapolis Heart Institute Foundation

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00268307 Dec 2005 → Jan 2010 acute myocardial infarction Minneapolis Heart Institute Foundation Completed Missed primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous, Unfractionated Bone Marrow Mononuclear Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00268307 ↗
Route Other “Intracoronary infusion of Autologous, Unfractionated Bone Marrow Mononuclear Cells.” NCT00268307 ↗